Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19)
NCT ID: NCT04372004
Last Updated: 2020-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
100 participants
INTERVENTIONAL
2020-05-08
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Performance Evaluation of RealDetect™ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus
NCT04403672
Rapid Detection of COVID-19 by Portable and Connected Biosensor
NCT04367142
NAC for Attenuation of COVID-19 Symptomatology
NCT05074121
Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test
NCT04557046
COVID-19 SARS-CoV-2 Antibody Testing Study
NCT05009888
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Viral RNA test using nasopharyngeal swab
diagnostic tests for COVID-19 infection
Compare the efficacy of diagnostic tests for COVID-19 infection in detecting antibodies and viral-RNA
Viral RNA test using sputum
diagnostic tests for COVID-19 infection
Compare the efficacy of diagnostic tests for COVID-19 infection in detecting antibodies and viral-RNA
Serology test using blood
diagnostic tests for COVID-19 infection
Compare the efficacy of diagnostic tests for COVID-19 infection in detecting antibodies and viral-RNA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
diagnostic tests for COVID-19 infection
Compare the efficacy of diagnostic tests for COVID-19 infection in detecting antibodies and viral-RNA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current symptoms of COVID-19 ; fever alone or fever and at least one of the following symptoms need to be present
* Dry cough
* Sore throat
* Shortness of breath
* Chills
* Muscle pain
* Headache
* New loss of taste or smell
* Chills with repeated shaking
Exclusion Criteria
* Unwilling to undergo bi-weekly serological test during the 1-month enrollment
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Texas Cardiac Arrhythmia Research Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrea Natale
Executive Medical Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Texas Cardiac Arrhythmia Institute
Austin, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Deb Cardinal, RN MBA
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Angel Mayedo, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TCAI_CATCH COVID-19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.